CLASS II Drug recall · Reported 24 Aug 2022 · FDA Enforcement Report

Ketorolac Tromethamine Injection, USP 60 mg/ (30 mg/mL) recalled

Nephron Sc is recalling Ketorolac Tromethamine Injection, USP 60 mg/ (30 mg/mL), distributed nationwide in the US. The recall was initiated on 10 Aug 2022 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codesLot#: 023011 Exp 8/31/2022
NDC0487-6232
Quantity recalled5040 vials

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

Recall details

Recall number
D-1354-2022
FDA event ID
90703
Recalling firm
Nephron Sc, West Columbia, SC
Manufacturer
Nephron Pharmaceuticals Corporation
Classification
Class II
Status
Terminated
Recall initiated
10 Aug 2022
FDA classified
17 Aug 2022
Reported
24 Aug 2022
Type
Voluntary: Firm initiated
Customers notified by
Letter
Drug class
Pain Medication

Timeline

10 Aug 2022Recall initiated by company
17 Aug 2022Classified by FDA+7 days
24 Aug 2022Published in enforcement report+7 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

cGMP Deviations: deviations leading to potential cross-contamination.

Product as listed by the FDA

Ketorolac Tromethamine Injection, USP 60 mg/2 mL (30 mg/mL), packaged in 2 mL single dose vials, Rx Only, Nephron Pharmaceutical Corporation 4500 12th Street Extension West Columbia, SV 29172, NDC 0487-6232-01

Where it was distributed

USA Nationwide

Nationwide

Questions about this recall

Is Ketorolac Tromethamine Injection, USP 60 mg/ (30 mg/mL) recalled?

Yes. Nephron Sc recalled Ketorolac Tromethamine Injection, USP 60 mg/ (30 mg/mL) on 10 Aug 2022. The recall is Class II and its status is Terminated. Recall number D-1354-2022.

Why was it recalled?

cGMP Deviations: deviations leading to potential cross-contamination.

Which lots are affected?

Lot#: 023011 Exp 8/31/2022

Where was it sold?

USA Nationwide

What should I do if I have it?

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 21 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

More recalls from Nephron Sc

All 7

Other Ketorolac Tromethamine recalls

All 19
ReportedClassRecallCompanyReasonWhere
DrugCLASS IIKetorolac Tromethamine Injection, USP, 60 mg recalled by Aspiro PharmaKetorolac TromethamineAspiro PharmaParticulate MatterNationwide
DrugCLASS IIKetorolac Tromethamine Ophthalmic Solution recalled by ApotexKetorolac TromethamineApotexSterilityNationwide
DrugCLASS IIKetorolac Tromethamine Ophthalmic Solution recalled by ApotexKetorolac TromethamineApotexSterilityNationwide
DrugCLASS IKetorolac Tromethamine Injection, USP, 30 mg per mL recalledKetorolac TromethamineFresenius Kabi USAParticulate MatterNationwide
DrugCLASS IIKetorolac Tromethamine Injection, USP, 60 mg per (30 mg per mL) recalledKetorolac TromethamineFresenius Kabi USAParticulate MatterNationwide